StockData
Eloxx Pharmaceuticals, Inc. logo

Eloxx Pharmaceuticals, Inc. (ELOX) stock

ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$12.75−0.40 (-3.04%)

Close on Nov 16, 2026Market cap $86.56MP/E –Yield –

Eloxx Pharmaceuticals ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Eloxx Pharmaceuticals's ebitda for the twelve months ending Jun 30, 2016 was -$11.10M. For fiscal 2016 it was -$11.10M. The highest annual figure on record is -$4.36M in fiscal 2013.

Annual ebitda

PeriodPeriod endValueChange
FY2016Jun 30, 2016-$11.10M–
FY2015Jun 30, 2015-$17.90M–
FY2014Jun 30, 2014-$8.80M–
FY2013Jun 30, 2013-$4.36M–
FY2012Jun 30, 2012-$5.15M–
FY2011Jun 30, 2011-$7.78M–
FY2010Jun 30, 2010-$4.72M–

Quarterly ebitda

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2016CQ2 2016Jun 30, 2016-$1.38M–
Q3 FY2016CQ1 2016Mar 31, 2016-$4.87M–
Q2 FY2016CQ4 2015Dec 31, 2015-$3.73M–
Q1 FY2016CQ3 2015Sep 30, 2015-$1.12M–
Q4 FY2015CQ2 2015Jun 30, 2015-$880.91K–
Q3 FY2015CQ1 2015Mar 31, 2015-$1.19M–
Q2 FY2015CQ4 2014Dec 31, 2014-$10.71M–
Q1 FY2015CQ3 2014Sep 30, 2014-$5.13M–
Q4 FY2014CQ2 2014Jun 30, 2014-$3.57M–
Q3 FY2014CQ1 2014Mar 31, 2014-$2.04M–

More Eloxx Pharmaceuticals figures

See a number that looks wrong?